A review of therapeutic agents for the management of pulmonary arterial hypertension

被引：10

作者：

Hahn, Stella S. ^{[1
]}

Makaryus, Mina ^{[1
]}

Talwar, Arunabh ^{[1
]}

Narasimhan, Mangala ^{[1
]}

Zaidi, Gulrukh ^{[1
]}

机构：

[1] Northwell Hlth, Div Pulm Crit Care & Sleep Med, 410 Lakeville Rd,Suite 107, New Hyde Pk, NY 11042 USA

来源：

THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE | 2017年 / 11卷 / 01期

关键词：

pulmonary arterial hypertension; prostanoid; endothelin receptor antagonist; phosphodiesterase inhibitor; soluble guanylate cyclase stimulator; ENDOTHELIN RECEPTOR ANTAGONIST; RANDOMIZED CONTROLLED-TRIAL; CONTINUOUS INTRAVENOUS EPOPROSTENOL; NITRIC-OXIDE SYNTHASE; 5 INHIBITOR THERAPY; DOUBLE-BLIND; INHALED ILOPROST; ORAL TREPROSTINIL; COMBINATION THERAPY; PROSTACYCLIN ANALOG;

D O I：

10.1177/1753465816665289

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

Pulmonary arterial hypertension (PAH) is an uncommon, progressive and life threatening disease characterized by a proliferative vasculopathy of the small muscular pulmonary arterioles resulting in elevated pulmonary vascular resistance and eventually right ventricular failure. An increasing understanding of the pathobiology of PAH and its natural history has led to the development of numerous targeted therapies. Despite these advances there is significant progression of disease and the survival rate remains low. This article reviews the agents currently available for the medical management of PAH.

引用

页码：46 / 63

页数：18

共 50 条

[21] Comprehensive review on novel targets and emerging therapeutic modalities for pulmonary arterial Hypertension
Dhoble, Sagar
Patravale, Vandana
Weaver, Edward
Lamprou, Dimitrios A.
Patravale, Tanmay
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2022, 621
[22] Chronic thromboembolic pulmonary arterial hypertension: a review of the literature and novel therapeutic approaches
Androulakis, Emmanuel
Lioudaki, Eirini
Christophides, Theodoros
Ahmad, Mahmood
Fayed, Hossam
Laskar, Nabila
Schreiber, Benjamin
EXPERT REVIEW OF RESPIRATORY MEDICINE, 2015, 9 (03) : 351 - 359
[23] Novel therapeutic perspectives in pulmonary arterial hypertension
Humbert, M
Sitbon, O
Simonneau, G
EUROPEAN RESPIRATORY JOURNAL, 2003, 22 (02) : 193 - 194
[24] Novel Therapeutic Approaches of Pulmonary Arterial Hypertension
Tyagi, Sanjay
Batra, Vishal
INTERNATIONAL JOURNAL OF ANGIOLOGY, 2019, 28 (02) : 112 - 117
[25] THERAPEUTIC EFFECTS OF ALOPERINE ON THE PULMONARY ARTERIAL HYPERTENSION
Li, Shuang
Zhou, Fubo
Dong, Jianjiang
Dong, Qi
Luan, Hairong
Li, Li
Hao, Yankun
FARMACIA, 2019, 67 (04) : 691 - 701
[26] Current Therapeutic Approaches to Pulmonary Arterial Hypertension
Galie, Nazzareno
Palazzini, Massimiliano
Leci, Enri
Manes, Alessandra
REVISTA ESPANOLA DE CARDIOLOGIA, 2010, 63 (06): : 708 - 724
[27] Therapeutic implications of microRNAs in pulmonary arterial hypertension
Lee, Aram
McLean, Danielle
Choi, Jihea
Kang, Hyesoo
Chang, Woochul
Kim, Jongmin
BMB REPORTS, 2014, 47 (06) : 311 - 317
[28] Therapeutic strategy in the treatment of pulmonary arterial hypertension
Perrone, Sergio V.
INSUFICIENCIA CARDIACA, 2009, 4 (01) : 33 - 43
[29] Promising therapeutic approaches in pulmonary arterial hypertension
Ali, Md Khadem
Ichimura, Kenzo
Spiekerkoetter, Edda
CURRENT OPINION IN PHARMACOLOGY, 2021, 59 : 127 - 139
[30] Udenafil as a Therapeutic Option for Pulmonary Arterial Hypertension
Kim, Hyung Yoon
Kim, Kye Hun
KOREAN CIRCULATION JOURNAL, 2019, 49 (04) : 361 - 362

← 1 2 3 4 5 →